Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 296-297, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Phagocytic Function of Monocytes in Children with
Human Immunodeficiency Virus Type 1 Infection
Gratiela
Tardei,1,*
Dan
Duiculescu,2
Christian
Capo,3
Carmen-Cristina
Diaconu,1
Adrian
Mutiu,1
Jean-Louis
Mege,3 and
Costin
Eugen
Cernescu1
St. S. Nicolau Institute of
Virology1 and Victor Babes Hospital of
Infectious and Tropical Diseases,2 Bucharest,
Romania, and Unité des Rickettsies, CNRS UPRESA 6020, Faculté de Médecine, Marseille,
France3
Received 22 July 1999/Returned for modification 30 September
1999/Accepted 14 December 1999
 |
ABSTRACT |
We investigated the phagocytic function of monocytes in 7- to
10-year-old children horizontally infected with human immunodeficiency virus type 1 (HIV-1) in comparison to that in healthy sex- and age-matched controls. CR3-mediated phagocytosis was increased in
patients with HIV-associated pulmonary tuberculosis, independently of
CD4 counts and p24 antigenemia.
 |
TEXT |
Human immunodeficiency virus (HIV)
infection significantly increases susceptibility to common pathogens
and favors the occurrence of opportunistic infections. The increased
susceptibility to common infections has been related to abnormal
antibody response to specific antigens (5, 15), while the
occurrence of opportunistic infections is associated with mononuclear
phagocyte system dysfunction (4). Indeed, monocytes and
macrophages are known to play an essential role in the defense against
intracellular microorganisms (10). These cells also
represent targets and long-term hosts for HIV replication with
subsequent cell function dysregulation (12, 14).
Phagocytosis is one of the primary antimicrobial functions of monocytes
and macrophages. Unlike the case of Fc receptors, phagocytosis mediated
by complement receptors seems to facilitate the intracellular survival
of invading pathogens (9).
Pediatric HIV infection with a particular subtype of HIV type 1 (HIV-1), subtype F, is characteristic of the Romanian AIDS epidemic
(1, 7). A high rate of tuberculosis (TB) is noted among
HIV-infected Romanian children with moderate and severe immune
deficiency. A diagnosis of TB in HIV-infected children is difficult,
and the occurrence of TB significantly worsens the clinical evolution,
suggesting that the Mycobacterium tuberculosis infection is
critical in the outcome of pediatric HIV disease.
In the present study, we addressed the question whether monocyte
phagocytosis, dependent or not on opsonins, is modified in HIV-1-infected Romanian children. We also investigated the relationship between the clinical, immunological, and virological status of patients
and potential monocyte phagocytosis abnormalities.
Forty-one HIV-1-infected children (24 boys and 17 girls), aged 7 to 10 years, and naive of antiretroviral and intravenous immunoglobulin
therapy, were studied. Ten sex- and age-matched healthy subjects
presenting for hepatitis B virus vaccination were enrolled as controls.
Informed consent was obtained from the parents of each child. HIV-1
infection was horizontally acquired in all studied patients, most
probably before 2 years of age. The clinical status of HIV-infected
children was evaluated in accordance with the 1994 revised
Centers for Disease Control (CDC) classification (6).
At the moment of testing, 24 of these children were devoid of
intercurrent infections (ICI), while 8 had pulmonary TB and 9 had
non-TB ICI, i.e., bacterial pneumonia, oropharyngeal candidiasis,
otitis media, or dysentery. CD4 counts were determined with the Manual
CD4 Count Kit (Coulter, Miami, Fla.), and p24 antigenemia was measured
after immune complex dissociation (ICD) with an HIV-1 p24 antigen
enzyme-linked immunosorbent assay and ICD Prep Kit (Coulter). Monocyte
phagocytosis was assessed by an in vitro test as previously described
(13). Briefly, monocytes were isolated by Ficoll gradient
centrifugation followed by adherence to Lab-Tek chamber slides (Nunc,
Naperville, Ill.). Zymosan was extemporaneously labeled with
fluorescein isothiocyanate and then opsonized with autologous serum.
Duplicate wells of adhered monocytes were incubated for 30 min with a
1-mg/ml concentration of fluorescein isothiocyanate-zymosan in RPMI
1640 medium and then washed with cold phosphate-buffered saline to
remove unattached particles, fixed with formaldehyde, and
counterstained with Evans blue dye. Slides were examined with a
fluorescence microscope by an investigator unaware of the clinical
status of the tested subjects. At least 150 cells were counted for each
test well. Cells having internalized at least one particle were
considered positive and were counted along with their associated
zymosan particles. The phagocytosis index (PI) was defined as the
number of particles internalized by 100 positive cells. Statistical
analysis was conducted with a two-tailed Student t test and
Pearson correlation.
We used unopsonized and opsonized zymosan to investigate mainly the
complement receptor 3 (CR3)-mediated monocyte phagocytosis since these
particles bind to distinct domains of CR3. The
-glucans, which are
the major carbohydrate component of zymosan, bind to the lectin-binding
domain of the CR3
chain, while opsonized zymosan particles also
bind the
chain of CR3 to its interactive domain (I domain)
(16). Phagocytosis of zymosan particles by monocytes was
studied in HIV-infected children and healthy controls, and no
significant differences were seen when they were globally analyzed.
Opsonization increased zymosan phagocytosis by monocytes similarly in
HIV-infected children and controls. We did not find significant
differences between either PI values or percentages of monocytes
ingesting zymosan particles among HIV groups split according to the CDC
clinical classification. PI values of only opsonized zymosan were
significantly increased in children with advanced HIV disease (clinical
category C) in comparison to healthy controls (453 ± 158 [mean ± standard deviation] versus 340 ± 19, P < 0.05). CD4 counts significantly correlated with p24 antigenemia (r =
0.3497, P < 0.05) and with the CDC
clinical category (Table 1), but there
was no significant correlation between phagocytosis parameters and
either CD4 counts or p24 antigenemia.
The relationship between the ICI status of patients and monocyte
phagocytosis was then investigated. Phagocytosis parameters for
unopsonized and opsonized zymosan were similar in children without ICI,
children with non-TB ICI, and healthy controls (Fig. 1). In contrast, we found a significant
increase in the uptake of unopsonized and opsonized zymosan in
HIV-infected children with TB in comparison to that in controls and
HIV-infected children either with non TB-ICI or without ICI (Fig. 1).
The fact that six of these children fell into clinical category C and
two fell into the clinical category B suggests that pulmonary TB rather than the clinical stage of HIV infection affects the phagocytic ability
of monocytes.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
PI values and percentages of monocytes ingesting zymosan
particles (positive cells) in controls and the group of HIV-infected
children divided by their ICI status. PI values (bars) and percentages
of positive cells (circles) are significantly higher in patients
infected with pulmonary TB than in controls (P < 0.05)
or HIV-infected children either with non-TB ICI (P < 0.02) or free of ICI (P < 0.05), for both types
of zymosan particles, i.e., unopsonized (closed bars and circles) and
opsonized (open bars and circles). Data are means ± standard
deviations.
|
|
Our study shows that CR3-mediated monocyte phagocytosis is not
significantly affected in Romanian children infected with HIV-1 who are
naive of antiretroviral and intravenous immunoglobulin therapy,
provided that they do not experience TB infection. A pathway-specific
increase in CR3-mediated monocyte phagocytosis was seen only in
HIV-infected children experiencing pulmonary TB. Previous reports show
that monocyte phagocytosis in HIV-infected adults is normal or reduced
compared to that in healthy controls (3, 8, 11). The
monocyte phagocytosis has been found to be amplified in
less-symptomatic HIV-infected adults (2, 8). The CD4 count
of adults with AIDS (8) and the viral load of HIV-infected
individuals (3) have been shown to correlate with the
phagocytic activity of monocytes. However, our results did not show a
significant correlation between phagocytosis parameters and the
virological and immunological markers. The mechanisms of the increased
CR3-mediated phagocytosis observed in HIV-infected children with TB
could be explained by CR3 overexpression and/or by a
conformation-dependent increase of CR3 avidity. These situations might
be induced by cytokines released in response to M. tuberculosis infection. Since M. tuberculosis enters
monocytes and macrophages via complement receptors, it is predictable
that the increase in CR3-mediated phagocytosis could favor the
intracellular uptake of bacteria and the subsequent development or
dissemination of TB. We believe that our results should trigger further
assessment of monocyte phagocytosis as a potential tool in predicting
and managing opportunistic infections during pediatric HIV infection.
 |
ACKNOWLEDGMENTS |
This work was supported by the Romanian Academy's grant
GAR 106/1997.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: St. S. Nicolau
Institute of Virology, sos. Mihai Bravu 285, Bucharest 79650, Romania. Phone: 401 324 25 90. Fax: 401 321 18 13. E-mail:
gtardei{at}hotmail.com.
 |
REFERENCES |
| 1.
|
Apetrei, C.,
A. Necula,
C. Holm-Hansen,
I. Loussert-Ajaka,
I. Pandrea,
C. Cozmei,
A. Streinu-Cercel,
F. R. Pascu,
E. Negut,
G. Molnar,
M. Duca,
M. Pecec,
F. Brun-Vezinet, and F. Simon.
1998.
HIV-1 diversity in Romania.
AIDS
12:1079-1085[CrossRef][Medline].
|
| 2.
|
Bandres, J. C.,
J. Trial,
D. M. Musher, and R. D. Rossen.
1993.
Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection.
J. Infect. Dis.
168:75-83[Medline].
|
| 3.
|
Baqui, A. A.,
T. F. Meiller,
M. Zhang, and W. A. Falkler, Jr.
1999.
The effects of HIV viral load on the phagocytic activity of monocytes activated with lipopolysaccharide from oral microorganisms.
Immunopharmacol. Immunotoxicol.
21:421-438[Medline].
|
| 4.
|
Bender, B. S.,
B. L. Davidson,
R. Klein,
C. Brown, and T. C. Quinn.
1988.
Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Rev. Infect. Dis.
10:1142-1154[Medline].
|
| 5.
|
Bernstein, L. J.,
H. D. Ochs,
R. J. Wedgwood, and A. Rubinstein.
1985.
Defective humoral immunity in pediatric acquired immune deficiency syndrome.
J. Pediatr.
107:352-357[CrossRef][Medline].
|
| 6.
|
Centers for Disease Control and Prevention.
1994.
1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age.
Morbid. Mortal. Weekly Rep.
43:1-7.
|
| 7.
|
Cernescu, C. E.,
G. Tardei,
A. Necula,
S. M. Ruta, and C.-P. Pau.
1994.
The serologic significance of F viral genotype for human immunodeficiency virus type 1 epidemic.
J. Infect. Dis.
170:1043-1044[Medline].
|
| 8.
|
Dobmeyer, T. S.,
B. Raffel,
J. M. Dobmeyer,
S. Findhammer,
S. A. Klein,
D. Kabelitz,
D. Hoelzer,
E. B. Helm, and R. Rossol.
1995.
Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts.
Eur. J. Med. Res.
1:9-15[Medline].
|
| 9.
|
Kaufmann, S. H.
1993.
Immunity to intracellular bacteria.
Annu. Rev. Immunol.
11:129-163[CrossRef][Medline].
|
| 10.
|
Langermans, J. A.,
W. L. Hazenbos, and R. van Furth.
1994.
Antimicrobial functions of mononuclear phagocytes.
J. Immunol. Methods
174:185-194[CrossRef][Medline].
|
| 11.
|
Roilides, E.,
A. Holmes,
C. Blake,
P. A. Pizzo, and T. J. Walsh.
1993.
Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus.
J. Infect. Dis.
168:562-565.
|
| 12.
|
Roulston, A.,
R. Lin,
P. Beauparlant,
M. A. Wainberg, and J. Hiscott.
1995.
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF- B/Rel transcription factors.
Microbiol. Rev.
59:481-505[Abstract/Free Full Text].
|
| 13.
|
Sanguedolce, M. V.,
C. Capo,
P. Bongrand, and J. L. Mege.
1992.
Zymosan-stimulated tumor necrosis factor- production by human monocytes. Down-modulation by phorbol ester.
J. Immunol.
148:2229-2236[Abstract].
|
| 14.
|
Schuitemaker, H., and F. Miedema.
1996.
Viral and cellular determinants of HIV-1 replication in macrophages.
AIDS
10(Suppl. A):S25-S32.
|
| 15.
|
Szelc, C. M.,
C. Mitcheltree,
L. R. Roberts, and E. R. Stiehm.
1992.
Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection.
J. Infect. Dis.
166:486-493[Medline].
|
| 16.
|
Thornton, B. P.,
V. Vetvicka,
M. Pitman,
R. C. Goldman, and G. D. Ross.
1996.
Analysis of the sugar specificity and molecular location of the -glucan binding lectin site of complement receptor type 3 (CD11b/CD18).
J. Immunol.
156:1235-1246[Abstract].
|
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 296-297, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.